When Bipolar and ADHD Overlap: Treatment 2 December 2, 2024 Kellie Newsome, PMHNP and Chris Aiken, MD How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.Read More
When Bipolar and ADHD Overlap: Treatment 1 November 25, 2024 Kellie Newsome, PMHNP and Chris Aiken, MD How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.Read More
When Bipolar and ADHD Overlap: Diagnosis November 18, 2024 Kellie Newsome, PMHNP and Chris Aiken, MD You’ll never be 100% sure if a patient has bipolar, ADHD, or both, but we’ll get you as close as we can.Read More
Psychopharm Secrets: What Patients Won’t Tell You November 4, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.Read More
Top 10 Findings: Alcohol, ADHD, and Antipsychotics October 28, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP A new med combo for alcohol use disorder, antipsychotic dose reduction in schizophrenia, and two new tips for using stimulants in ADHD.Read More
Top 10 Findings: Lithium, Lumateperone, and Lavender October 21, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP New studies change how we think about lithium and weight gain, and updates on lumateperone, lavender, and esketamine in depression. Read More
Top 10 Findings of Past Year: Treatment Resistant Depression and Benzos October 14, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP We count down the top 10 research updates of the past year with a focus on treatment resistant depression and benzo withdrawal.Read More
Cobenfy: A New Antipsychotic October 7, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.Read More
PTSD 101: Nine Off-Label Meds September 23, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.Read More
PTSD 101: Prazosin or SSRI? September 17, 2024 Chris Aiken, MD and Kellie Newsome, PMHNP Should we follow the FDA and give SSRIs, or venture off-label with the fabled prazosin?Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
General PsychiatryPsychopharm Secrets: What Patients Won’t Tell YouHow to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024